🔥MORPHEUS-Phase Ib/II Liver study: Tiragolumab in combination with AtezoBev in #hepatocellularcarcinoma #ASCO23
👉Interesting signal of activity for anti-TIGIT 💊in #HCC (despite control arm 🤨), looking forward to IMbrave152/ SKYSCRAPER-14
ESMO - Eur. Oncology OncoAlert EASL Education EASL Education
#AudioVisualAbstract : Open Versus Laparoscopic #RightHepatectomy for #HepatocellularCarcinoma Following Sequential TACE–PVE : A Multicentric Comparative Study Goumard Claire Hôpital Pitié Salpêtrière - AP-HP Sorbonne Université
rdcu.be/drWfw
HOPE for the Week: The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation.
#HOPEForTheWeek #HepatocellularCarcinoma
onlinelibrary.wiley.com/doi/10.1111/ao…
#AudioVisualAbstract : #TransferrinReceptor is Associated with Sensitivity to #FerroptosisInducers in #HepatocellularCarcinoma
rdcu.be/dv2zS
#AudioVisualAbstract : Treatment #Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I–II #HepatocellularCarcinoma Douglas Swords Timothy Newhook Jean-Nicolas Vauthey MD MD Anderson Cancer Center
rdcu.be/dFp69
Lisa Newman, MD MPH
Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update - Erman Akkus
oncodaily.com/36392.html
#AnkaraUniversity #Cancer #Durvalumab #ESMO #HCC #HepatocellularCarcinoma #OncoDaily #Oncology #Sorafenib
🎙️SBRT showed ⬆️local antitumoral activity for #HCC than TACE-DEB, w/o detrimental effects on OS, tox & QoL‼️ OncoAlert IJROBP - The Red Journal
📌Ph3 RCT: TACE-DEB ✖️ SBRT treatments for #hepatocellularcarcinoma (HCC)
TACE-DEB : Max 4 procedures; ablation allowed after incomplete TACE-DEB
#AdvancedGlycationEndproduct (AGE)⏫liver matrix #Viscoelasticity (Collagen bundle network with shorter fibers & smaller angles), but not #Stiffness
#T2DM #NASH #MASH
A mechanosensitive integrin β1–Tensin 1– #YAP cascade (⏫by high Viscoelasticity) ⏫ #HepatoCellularCarcinoma
Thank you ESMO - Eur. Oncology for the invitation as Faculty in the just concluded ESMO Preceptorship on Liver Cancer – the first ESMO educational course held in Kenya!
It was such a pleasure and a great learning experience! #Quality #standardofcare #livercancer #hepatocellularcarcinoma
Researchers found a correlation between adverse events and clinical outcomes in a study of patients with #hepatocellularCarcinoma who were treated with atezolizumab combined with bevacizumab. Reported in Targeted Oncology. bit.ly/3ULFC70 #HCC
Happy to announce I'll be presenting our work on the changing treatment patterns for #HepatocellularCarcinoma at the upcoming ASCO Medical Student & Resident Abstract Forum. Thank you Dana-Farber Division of Population Sciences and Chris Manz for the support on this important topic. #LiverTwitter #GItwitter
Ablation of left lobe heptocellular carcinoma HCC with good results UT Houston_IR
#InterventionalRadiology #InterventionalOncology #minimallyinvasiveprocedures #IAmIR #HepatocellularCarcinoma #HVC #Cancer #Therapy #Management #GlobalEducation #ablation #LocalRegionalTherapy
#TACE + #Durvalumab + #Bevacizumab demonstrates superior PFS (23% reduced risk) when compared to #TACE alone for the treatment of #hepatocellularcarcinoma .
Congratulations to the #Emerald1 investigators. Welcome the #combinationtherapy era.🧩
astrazeneca.com/media-centre/p…
🟪New Article in press❕
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multi-center real world study with focus on bleeding and thromboembolic events
🔓 #OpenAccess at 👉jhep-reports.eu/article/S2589-…
#LiverTwitter
#HepatocellularCarcinoma
#HCC
#tb to 2022 ⬅️
Study Protocol: Adjuvant Holmium-166 #Radioembolization After #RadiofrequencyAblation in Early-Stage #HepatocellularCarcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)
link.springer.com/article/10.100…
#OpenAccess 🔓
PUBLISHED: #PerioperativeLymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following #Hepatectomy for #HepatocellularCarcinoma . rdcu.be/dvHlB Society of Surgical Oncology
🟪NEW Article in press❕
Applications of single-cell multi-omics in liver cancer
🔓 #OpenAccess at 👉jhep-reports.eu/article/S2589-…
#LiverTwitter
#HepatocellularCarcinoma
#HCC